Crystal polymorphism of aminoethylphenoxyacetic acid derivative
    1.
    发明授权
    Crystal polymorphism of aminoethylphenoxyacetic acid derivative 失效
    氨基乙基苯氧基乙酸衍生物的晶体多晶型

    公开(公告)号:US06376707B1

    公开(公告)日:2002-04-23

    申请号:US09889857

    申请日:2001-07-23

    IPC分类号: C07C22900

    CPC分类号: C07C217/60 C07C213/10

    摘要: The present invention relates to a crystalline polymorph of 2-[4-[2-[[(1S,2R)-2-hydroxy-2-(4-hydroxy-phenyl)-1-methylethyl]amino]ethyl]phenoxy]acetic acid having strong diffraction peaks (diffraction angle: 2&thgr;±0.1°) at 10.8, 19.1, 19.3, 19.8, 20.6 and 27.0° in powder X-ray diffraction pattern, which has potent &bgr;2- and &bgr;3-adrenoceptor stimulating effects and is useful as an agent for relieving pain and promoting the removal of calculi in urolithiasis, and the like. For example, the crystalline polymorph can be prepared by hydrolyzing ethyl 2-[4-[2-[[(1S,2R)-2-hydroxy-2-(4-hydroxyphenyl)-1-methylethyl]-amino]ethyl]phenoxy]acetate phosphate by sodium hydroxide, adding an aqueous phosphoric acid solution at 40° C. and over, adding a mixed solvent of water and methanol or methanol to the resulting compound, and stirring the suspension at 40° C. to reflux temperature for 30 minutes to several hours.

    摘要翻译: 本发明涉及2- [4- [2 - [[(1S,2R)-2-羟基-2-(4-羟基 - 苯基)-1-甲基乙基]氨基]乙基]苯氧基]乙酸的结晶多晶型物 在其粉末X射线衍射图中,在10.8,19.1,19.3,19.8,20.6和27.0°处具有强衍射峰(衍射角:2θ±0.1°)的酸,其具有有效的β2-和β3-肾上腺素受体刺激作用,并且是有用的 作为缓解疼痛并促进尿石结石中的结石的去除的药剂等。 例如,结晶多晶型物可以通过水解2- [4- [2 - [[(1S,2R)-2-羟基-2-(4-羟基苯基)-1-甲基乙基] - 氨基]乙基]苯氧基 ]乙酸磷酸盐与氢氧化钠反应,在40℃加入磷酸水溶液,过滤,向所得化合物中加入水和甲醇或甲醇的混合溶剂,并在40℃下将悬浮液在回流温度下搅拌30 几分钟到几个小时。

    PROCESS FOR PRODUCTION OF GLUCOPYRANOSYLOXYPYRAZOLE DERIVATIVE
    4.
    发明申请
    PROCESS FOR PRODUCTION OF GLUCOPYRANOSYLOXYPYRAZOLE DERIVATIVE 有权
    生产葡萄糖酰氧基吡唑衍生物的方法

    公开(公告)号:US20090062518A1

    公开(公告)日:2009-03-05

    申请号:US11908693

    申请日:2006-03-16

    IPC分类号: C07H1/00

    CPC分类号: C07H17/02

    摘要: The present invention relates to a method for preparing the glucopyranosyloxypyrazole derivatives which are useful as agents for the prevention or treatment of a disease associated with hyperglycemia such as diabetes, diabetic complications, obesity or the like.A glucopyranosyloxypyrazole derivative can be easily and efficiently prepared by allowing a benzylpyrazole derivative represented by the general formula: wherein R1, R2, R3, R4 and R5 may be the same or different, for example each of them is a hydrogen atom, a halogen atom or an alkyl, alkoxy, arylmethyloxy group or the like, R6 is an alkyl group, for example R7 is a hydrogen atom or an alkyl, alkoxy, arylmethyloxy group or the like, to react with a compound represented by the general formula: wherein as an example, PG1 is a pivaloyl group or the like, as an example, X1 is a bromine atom or the like, therefore the present invention is extremely useful as a method for preparing pharmaceutical compounds.

    摘要翻译: 本发明涉及一种制备吡喃葡萄糖氧吡唑衍生物的方法,其可用作预防或治疗与糖尿病,糖尿病并发症,肥胖症等高血糖相关的疾病的药剂。 吡喃葡萄糖氧吡唑衍生物可以容易且有效地制备,其中R 1,R 2,R 3,R 4和R 5可以相同或不同,例如氢原子,卤原子 或烷基,烷氧基,芳基甲氧基等,R6是烷基,例如R7是氢原子或烷基,烷氧基,芳基甲氧基等,与通式表示的化合物反应:其中作为 作为实例,PG1是新戊酰基等,作为实例,X1是溴原子等,因此本发明作为制备药物化合物的方法是非常有用的。

    Process for production of glucopyranosyloxypyrazole derivative
    5.
    发明授权
    Process for production of glucopyranosyloxypyrazole derivative 有权
    吡喃葡萄糖氧吡唑衍生物的制备方法

    公开(公告)号:US08022192B2

    公开(公告)日:2011-09-20

    申请号:US11908693

    申请日:2006-03-16

    IPC分类号: C07H17/02 A61K31/7056

    CPC分类号: C07H17/02

    摘要: The present invention relates to a method for preparing the glucopyranosyloxypyrazole derivatives which are useful as agents for the prevention or treatment of a disease associated with hyperglycemia such as diabetes, diabetic complications, obesity or the like. A glucopyranosyloxypyrazole derivative can be easily and efficiently prepared by allowing a benzylpyrazole derivative represented by the general formula: wherein R1, R2, R3, R4 and R5 may be the same or different, for example each of them is a hydrogen atom, a halogen atom or an alkyl, alkoxy, arylmethyloxy group or the like, R6 is an alkyl group, for example R7 is a hydrogen atom or an alkyl, alkoxy, arylmethyloxy group or the like, to react with a compound represented by the general formula: wherein as an example, PG1 is a pivaloyl group or the like, as an example, X1 is a bromine atom or the like, therefore the present invention is extremely useful as a method for preparing pharmaceutical compounds.

    摘要翻译: 本发明涉及一种制备吡喃葡萄糖氧吡唑衍生物的方法,其可用作预防或治疗与糖尿病,糖尿病并发症,肥胖症等高血糖相关的疾病的药剂。 吡喃葡萄糖氧吡唑衍生物可以容易且有效地制备,其中R 1,R 2,R 3,R 4和R 5可以相同或不同,例如氢原子,卤原子 或烷基,烷氧基,芳基甲氧基等,R6是烷基,例如R7是氢原子或烷基,烷氧基,芳基甲氧基等,与通式表示的化合物反应:其中作为 作为实例,PG1是新戊酰基等,作为实例,X1是溴原子等,因此本发明作为制备药物化合物的方法是非常有用的。

    CRYSTAL POLYMORPH OF HYDROXYNOREPHEDRIN DERIVATIVE HYDROCHLORIDE
    6.
    发明申请
    CRYSTAL POLYMORPH OF HYDROXYNOREPHEDRIN DERIVATIVE HYDROCHLORIDE 失效
    羟基吗啡衍生化氢氯化物的晶体聚合物

    公开(公告)号:US20090069421A1

    公开(公告)日:2009-03-12

    申请号:US11912407

    申请日:2006-04-24

    CPC分类号: C07C217/60

    摘要: The present invention provides a novel crystal polymorph of ethyl (−)-2-[4-[2-[[1S,2R]-2-hydroxy-2-(4-hydroxyphenyl)-1-methylethyl]amino]ethyl]-2,5-dimethylphenoxyacetate hydrochloride which can be determined by characteristic diffraction peaks of the powder X-ray diffraction or the like, and obtained from ethyl (−)-2-[4-[2-[[1S,2R]-2-hydroxy-2-(4-hydroxyphenyl)-1-methylethyl]amino]ethyl]-2,5-dimethylphenoxyacetate by a specific method.

    摘要翻译: 本发明提供了( - ) - 2- [4- [2 - [[1S,2R] -2-羟基-2-(4-羟基苯基)-1-甲基乙基]氨基]乙基] 可以通过粉末X射线衍射等的特征衍射峰确定,并由( - ) - 2- [4- [2 - [[1S,2R] -2- 羟基-2-(4-羟基苯基)-1-甲基乙基]氨基]乙基] -2,5-二甲基苯氧基乙酸酯。

    Crystal polymorph of hydroxynorephedrin derivative hydrochloride
    7.
    发明授权
    Crystal polymorph of hydroxynorephedrin derivative hydrochloride 失效
    羟基去甲基苯酚衍生物盐酸盐的晶体多晶型物

    公开(公告)号:US07763654B2

    公开(公告)日:2010-07-27

    申请号:US11912407

    申请日:2006-04-24

    IPC分类号: A61K31/24 C07C229/00

    CPC分类号: C07C217/60

    摘要: The present invention provides a novel crystal polymorph of ethyl (−)-2-[4-[2-[[1S,2R]-2-hydroxy-2-(4-hydroxyphenyl)-1-methylethyl]amino]ethyl]-2,5-dimethylphenoxyacetate hydrochloride which can be determined by characteristic diffraction peaks of the powder X-ray diffraction or the like, and obtained from ethyl (−)-2-[4-[2-[[1S,2R]-2-hydroxy-2-(4-hydroxyphenyl)-1-methylethyl]amino]ethyl]-2,5-dimethylphenoxyacetate by a specific method.

    摘要翻译: 本发明提供了( - ) - 2- [4- [2 - [[1S,2R] -2-羟基-2-(4-羟基苯基)-1-甲基乙基]氨基]乙基] 可以通过粉末X射线衍射等的特征衍射峰确定,并由( - ) - 2- [4- [2 - [[1S,2R] -2- 羟基-2-(4-羟基苯基)-1-甲基乙基]氨基]乙基] -2,5-二甲基苯氧基乙酸酯。

    Process for preparing large-sized polymer particles
    10.
    发明授权
    Process for preparing large-sized polymer particles 失效
    制备大尺寸聚合物颗粒的方法

    公开(公告)号:US4694035A

    公开(公告)日:1987-09-15

    申请号:US823013

    申请日:1986-01-27

    CPC分类号: C08F257/02 C08F291/00

    摘要: A process for preparing large-sized polymer particles having a particle diameter in a range of 0.1 to 500 .mu.m by seeded polymerization is described, comprising:finely dispersing a polymerizable monomer in an aqueous medium to prepare a monomer dispersion in which a number average particle diameter of the resulting monomer droplets is not larger than that of seed particles, and a number average particle diameter in a semi-stable condition (Dm) of the monomer droplets satisfies, with a desired number average particle diameter of the final polymer particle as D, the following relation:0.5.times.D

    摘要翻译: 描述了通过接种聚合制备粒度在0.1至500μm范围内的大尺寸聚合物颗粒的方法,其包括:将可聚合单体细分散在水性介质中以制备单体分散体,其中数均粒子 所得单体液滴的直径不大于种子颗粒的直径,并且单体液滴的半稳定条件(Dm)中的数均粒径满足所需的最终聚合物颗粒的数均粒径为D 以下关系:将所述单体分散体与种子颗粒的分散体组合以使可聚合单体吸收或吸附在种子颗粒上的0.5×D < 并在聚合引发剂的存在下聚合可聚合单体。